Total raised
$20.0M
Last: Seed 2023-03
Stage
Seed
Founded
2021
Headcount
25
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. The company is building machine learning models combining deep proteomics to identify up to 1 million proteoforms, including post-translational modifications, protein-protein interactions, quantifications, and different structural populations of proteins.
Funding history · 2 rounds · $20.0M total
2023-03
Seed
$12.0M
2022-01
Seed
$8.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
data-analyticsbiotechnologydecision-supportdisease-managementproteinsdigital-healthcareartificial-intelligencedrug-discoverypersonalizationsoftware-platformpharma-companies